Find clinical trials for Glioblastoma (GBM) in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Glioblastoma (GBM) trials near Philadelphia, PA, USA:
efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 20 other locations
Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM)....
Phase 2
Philadelphia, Pennsylvania, United States
This research study is for Glioblastoma (GBM) patients who will be beginning Optune as part of their clinical care, which is a nove...
Philadelphia, Pennsylvania, United States and 1 other location
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Philadelphia, Pennsylvania, United States and 61 other locations
therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...
Phase 2, Phase 3
Pennington, New Jersey, United States and 8 other locations
INCMGA00012, and stereotactic radiosurgery (SRS) for recurrent Glioblastoma (GBM). The investigators hypothesize that the proposed ...
Phase 2
Philadelphia, Pennsylvania, United States
The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...
Phase 2
Philadelphia, Pennsylvania, United States and 22 other locations
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...
Philadelphia, Pennsylvania, United States and 132 other locations
(TMZ) in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma multiforme (GBM). The main questions it aims to an...
Phase 3
Philadelphia, Pennsylvania, United States and 7 other locations
receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM) expr...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal